Cellebrite DI Ltd. Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss
Cellebrite DI Ltd. (CLBT) reported Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss of $2.88 million for the 6-month period ending 2024-06-30, per its 6-K filed 2024-08-15.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments · last filed 2024-08-15
- 2024-06-30: Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month $2.88M.
- 2023-06-30: Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month $699.00K.
| Period end | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month |
|---|---|
| 2024-06-30 | $2.88M 6-K · filed 2024-08-15 |
| 2023-06-30 | $699.00K 6-K · filed 2024-08-15 |